Congenital Toxoplasmosis (CT) can have severe consequences. France, Austria, and Slovenia have prenatal screening programs whereas some other countries are considering universal screening to reduce congenital transmission and severity of infection in children. The efficiency of such programs is debated increasingly as seroprevalence among pregnant women and incidence of congenital toxoplasmosis show a steady decrease. In addition, uncertainty remains regarding the effectiveness of pre- and postnatal treatments.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Version of Record
Binquet, C., Lejeune, C., Seror, V., Peyron, F., Bertaux, A.C., Scemama, O., Quantin, C., Béjean, S., Stillwaggon, E., Wallon, M. (2019.) The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis. PLoS ONE 14(9): e0221709.
Required Publisher's Statement
This article was originally published on the publisher's website: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0221709